The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 339:127-128 July 9, 1998 Number 2
NextNext

Signal Transduction in Platelets from Patients with Polycythemia Vera

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Moliterno, A. R.
-PubMed Citation
To the Editor: In the February 26 issue, Moliterno et al.1 report on the reduced expression of the thrombopoietin receptor Mpl as a new characteristic of polycythemia vera and idiopathic myelofibrosis. On the basis of this reduced expression, they suggest a subsequent failure of activation of the Janus kinase signaling system due to an unknown upstream defect, with subsequent loss of phosphorylation of JAK2 and STAT5. After stimulation of platelets from normal subjects with thrombopoietin or thrombin, the authors observed tyrosine phosphorylation of proteins of approximately 125, 95, and 85 kd. Interestingly, this phosphorylation pattern could be observed in the . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.